DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | – | 1,020 | +405.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 202 | -94.3% | 0.00% | – |
| Q1 2023 | $5 | -28.6% | 3,526 | -22.7% | 0.00% | – |
| Q4 2022 | $7 | -99.6% | 4,563 | +127.6% | 0.00% | – |
| Q3 2022 | $2,000 | -91.3% | 2,005 | -68.4% | 0.00% | – |
| Q4 2021 | $23,000 | -67.1% | 6,350 | -61.1% | 0.00% | – |
| Q3 2021 | $70,000 | -4.1% | 16,341 | -0.6% | 0.00% | – |
| Q2 2021 | $73,000 | +3550.0% | 16,441 | +6372.8% | 0.00% | – |
| Q1 2021 | $2,000 | – | 254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |